By Devika Patel
Knoxville, Tenn., Dec. 12 - Momenta Pharmaceuticals, Inc. said it will raise $25.2 million in a registered direct placement of shares.
The company will sell 2.8 million common shares at $9.00 per share.
Leerink Swann LLC is the agent.
Proceeds will be used for general corporate and working capital purposes.
Momenta is a Cambridge, Mass.-based biotechnology company specializing in the characterization and engineering of complex drugs.
| Issuer: | Momenta Pharmaceuticals, Inc.
|
| Issue: | Common shares
|
| Amount: | $25.2 million
|
| Shares: | 2.8 million
|
| Price: | $9.00
|
| Warrants: | No
|
| Agent: | Leerink Swann LLC
|
| Pricing date: | Dec. 11
|
| Settlement date: | Dec. 16
|
| Stock symbol: | Nasdaq: MNTA
|
| Stock price: | $10.70 at close Dec. 11
|
| Market capitalization: | $396 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
